Target intelligence / Profile preview

Vascular smooth muscle contractile machinery and ion channels

Molecular classification
Ion channel, Enzyme, Other
01

Overview

The vascular smooth muscle (VSM) contractile machinery and ion channels constitute the primary physiological system for regulating vascular resistance and blood pressure. Contraction is driven by the interaction of actin and myosin, which is triggered by the phosphorylation of the 20-kDa myosin light chain (MLC20) by myosin light chain kinase (MLCK) (StatPearls, 2023). This process is highly dependent on intracellular calcium levels, which are primarily regulated by L-type voltage-gated calcium channels (VGCCs) and sarcoplasmic reticulum release (PubMed, PMID: 10951113). Relaxation occurs when myosin light chain phosphatase (MLCP) dephosphorylates MLC20, a process promoted by the nitric oxide/cGMP/PKG pathway and inhibited by the Rho-kinase (ROCK) pathway (NIH, 2022). Ion channels such as large-conductance calcium-activated potassium (BKCa) channels and ATP-sensitive potassium (KATP) channels modulate membrane potential to provide feedback regulation and induce vasodilation. Pharmacological targeting of these components is a cornerstone in treating hypertension and vasospastic disorders. For example, calcium channel blockers like amlodipine inhibit calcium influx, while ROCK inhibitors like fasudil prevent the inhibition of MLCP (PubChem, 2024). This target group is essential for maintaining hemodynamic stability but is often dysregulated in chronic cardiovascular diseases.

Other names
Vascular smooth muscle contractile apparatusVSM contractile machineryVascular smooth muscle ion channelsVSMC contractile system
02

Mechanism of action

Inhibition of L-type voltage-gated calcium channels to reduce calcium influx; activation of soluble guanylate cyclase to increase cGMP and activate myosin light chain phosphatase; inhibition of Rho-associated protein kinase (ROCK) to prevent phosphatase inhibition; and opening of potassium channels to induce membrane hyperpolarization.

03

Biological functions

Signal transductionOther
04

Disease associations

Cardiovascular disease
05

Safety considerations

Systemic hypotensionReflex tachycardiaPeripheral edemaHeadacheDizziness
06

Interacting drugs

Amlodipine

7 more in the full profile.

07

Biomarkers

Mean arterial pressureSystemic vascular resistanceMyosin light chain phosphorylation status

Beyond the preview

Go deeper on Vascular smooth muscle contractile machinery and ion channels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular smooth muscle contractile machinery and ion channels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call